Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ainos Inc | AIMD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.589999 | 07:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.589999 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.5019 - 1.83 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.589999 | USD |
Ainos Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 14.61M | 20.29M | - | 3.52M | -14.01M | -0.69 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ainos News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AIMD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.5701 | 0.60 | 0.56 | 0.5919031 | 18,986 | 0.0199 | 3.49% |
| 1 Month | 0.65 | 0.699 | 0.5019 | 0.6259708 | 76,865 | -0.06 | -9.23% |
| 3 Months | 0.60 | 0.864 | 0.5019 | 0.6431347 | 34,087 | -0.01 | -1.67% |
| 6 Months | 0.68 | 1.2194 | 0.5019 | 0.9701892 | 136,490 | -0.09 | -13.24% |
| 1 Year | 0.66 | 1.83 | 0.5019 | 1.22 | 313,688 | -0.07 | -10.61% |
| 3 Years | 3.72 | 3.75 | 0.5019 | 1.46 | 355,436 | -3.13 | -84.14% |
| 5 Years | 3.72 | 3.75 | 0.5019 | 1.46 | 355,436 | -3.13 | -84.14% |
Ainos Description
| Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low dose oral form. |
